NUVISAN GmbH: Funding, Investors & Team (Sep 2026)
Nuvisan Pharma Services is a global provider of product development and support services to the pharmaceutical, biotechnology and medical device industries. We deliver services ranging from a single test to fully integrated drug development programs.
NUVISAN GmbH has raised $9.6M across 1 funding round on record, the most recent a Grant of $9.6M announced in Sep 2022.
That round is above the $4.8M median round size for Health Care companies tracked on FundedIQ over the last two years.
NUVISAN GmbH Company Profile and Key Stats
Latest funding round on record: Sep 2022.
NUVISAN GmbH Funding Rounds
NUVISAN GmbH Founders and Leadership Team
No contact details are on record for this team yet.
NUVISAN GmbH Funding Compared to Other Health Care Startups
NUVISAN GmbH's latest round of $9.6M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like NUVISAN GmbH in Health Care and Neu-ulm
Companies Similar to NUVISAN GmbH
Arab Therapy functions as a startup that focuses on mental health.
Intu Diagnostics develops rapid and instrument-free solutions for infectious disease diagnostics, aiming for…
Maple Aviation is a medical logistics startup that specializes in building and operating autonomous drone…
Regulate is a wellness and performance company that provides science-backed breathwork programs and a mobile…
Avelios is a modular clinic platform that digitizes and optimizes all clinic processes in a user-friendly…
InflaRx (Nasdaq: IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary…
XO-Life.com is an online destination center. That provides services includes digital treatment monitoring and…
Wellster is the go-to solution for everyday consumer health. It builds digital clinics along the lifecycle of…
Berlin Heals Holding is a developer of implantable medical device for the cure of heart failure.
Recare is reevaluating the process of discharge management by utilizing digital tools to improve…
Altavo operates as a medical device startup. Altavo harness the power of machine learning and…
Prosoma is a medical company creating digital therapeutics products for cancer patients. We develop a…
NUVISAN GmbH Funding FAQs
What does NUVISAN GmbH do?
Nuvisan Pharma Services is a global provider of product development and support services to the pharmaceutical, biotechnology and medical device industries. We deliver services ranging from a single test to fully integrated drug development programs.
How much funding has NUVISAN GmbH raised?
NUVISAN GmbH has raised $9.6M across 1 round on record. The most recent is a Grant of $9.6M announced in Sep 2022.
When did NUVISAN GmbH last raise funding?
NUVISAN GmbH's most recent funding round on record is a Grant of $9.6M, announced in Sep 2022.
Who is the CEO of NUVISAN GmbH?
Dietrich Bruchmann is listed as CEO at NUVISAN GmbH.
Where is NUVISAN GmbH headquartered?
NUVISAN GmbH is based in Neu-ulm, Bayern, Germany.
How many employees does NUVISAN GmbH have?
NUVISAN GmbH is in the 1-10 employee band.
How does NUVISAN GmbH's funding compare to other Health Care startups?
NUVISAN GmbH's latest round of $9.6M is above the $4.8M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's NUVISAN GmbH Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for NUVISAN GmbH is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.